C677T Polymorphism of MTHFR gene in a Tunisian type 2 diabetic population;Polymorphisme C677T du gène de la MTHFR chez une population tunisienne diabétique de type 2

Immuno-Analyse et Biologie Specialisee

Volumn 23, Issue 4, 2008, Pages 220-223

  Oudi, M El ^a   Aouni, Z ^a   Mazigh, C ^a   Essaies, O ^a   Zidi, B ^a   Machghoul, S ^a  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

Author keywords

C677T mutation; Homocysteine; Type 2 diabetes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

ADULT; ARTICLE; DIABETIC PATIENT; DISEASE ASSOCIATION; ENZYME ASSAY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SAMPLE SIZE; TUNISIA;

EID: 51649117555     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2008.02.005     Document Type: Article

References (15)

1. Arai K., Yamasaki Y., Kajimoto Y., et al. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardiol infarction risk in NIDDM. Diabetes 46 (1997) 2102-2104
2. Bennouar N., Allami A., Azeddouk H., Bendriss A., et al. Thermolabile methylenetetrahydrofolate reductase C677T polymorphism and homocysteine are risk factors for coronary artery disease in Moroccan population. J Biomed Biotechnol 2007 1 (2007) 80687 Epub 2007
3. Buysschaert M., Gala J.L., Bessomo A., et al. C677T methylenetetrahydrofolate reductase mutation in type 2 diabetic patients with and without hyperhomocysteinemia. Diabetes metab 30 (2004) 349-354
4. Cacoub P., Gatel A., Sbai A., et al. Hyperhomocystéinémie, athérosclérose et thromboses artérielles et veineuses. Ann Med Intern 147 (1996) 352-360
5. Stephen M.S., Siskovick D.S., Malinow M.R., et al. myocardiol infarction in young women in relation to plasma total homocysteine, folate, and a commun variant in the methylenetetrahydrofolate reductase gene. Circulation 96 (1997) 412-417
6. Domogala T.B., Adamek L., Nizankowska E., et al. Mutations C677T and A1298C of the 5, 10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk venous thromboembolic disease. Blood Coagul Fibrinolysis 13 (2002) 423-431
7. Faucher C., Nivet-Antoine V., Mayara J., et al. Technique d'étude de quatre polymorphismes enzymatiques impliqués dans l'hyperhomocystéinémie. IBS 17 (2002) 251-256
8. Hankey G.J., Eikelboom J.W., Khoon W., et al. Clinical usefulness of plasma homocysteine in vascular disease. MJA 181 (2004) 314-318
9. Hankey G.J., and Eikelboom J.W. Homocysteine and stroke. Lancet 365 (2005) 194-196
10. Jeppe F., Klauss J., Peer G., et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood 104 (2004) 3046-3051
11. Livia P., Claudio C., Agostino G., et al. Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. Atherosclerosis 179 (2005) 333-338
12. Nabil M., Molka C., Martine V., Wassim W.A., et al. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract 75 (2007) 99-106
13. Kelly P.J., Shih V.E., Kistler P.J., et al. Low vitamin B6 but not homocysteine is associated with increased risk of stroke and transient ischemic attack in the era of folic acid grain fortification. Stroke 34 (2003) e51-e54
14. Petri M., Roubenoff R., Dallal G.E., et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematous. Lancet 348 (1996) 1120-1124
15. Sarah J.L., Shah E., and George D.S. Meta-analysis of MTHFR C677T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ 331 7524 (2005) 1053 Epub 2005